|

Hydroxychloroquine Sulfate Tablets Clinical Trials

2 actively recruiting trials

No change since May 2026

Pipeline

Phase 4: 1Phase 1/2: 1

Top Sponsors

  • Xingchen Peng1
  • Second Affiliated Hospital, School of Medicine, Zhejiang University1

Indications

  • Primary Sjögren's Syndrome1
  • Radiation-induced Oral Mucositis1
  • Arthritis1
  • Cancer1

Other2 trials

Hydroxychloroquine Sulfate Tablets for Radiation-induced Oral Mucositis
Phase 1/2
The Efficacy and Safety of Iguratimod (IGU) in the Treatment of Primary Sjögren's Syndrome
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.